40 results on '"Pulici, M"'
Search Results
2. The influence of length of stay in the ICU on power of discrimination of a multipurpose severity score (SAPS)
- Author
-
Sicignano, A., Carozzi, C., Giudici, D., Merli, G., Arlati, S., Pulici, M., and ARCHIDIA
- Published
- 1996
- Full Text
- View/download PDF
3. Posters
- Author
-
Ryan, D. W., Belyaev S., Rudnov V., Mironov A., Bhagwanjee, S., Muckart, D. J. J., Hodgson, R. E., Afessa, B., Meyers, B., Koch, K., Delke, I., Schelline, G., Meier, M., Haller, M., Briegel, J., Schüffel, W., Peter, K., Jones, C., Griffiths, R. D., Macmillan, R. R., Harris, C., Colardyn, F. A., Dheene, P., Danneels, C., Verstraete, A., Burn, L., Dawsen, B., Baudouin, S. V., Stoll, C., Schelling, G., Bullinger, M., Stott, S. A., Noble, D. W., Weir, J., Vesely, H., Gregor, Th., Defouillov, C., Defouilloy, I., Dimov, G., Tinturier, F., Slama, M., Ossart, M., Rosengaard, L. Bredahl, Eriksen, K., Nielsen, P. Rotbøll, Heslet, L., Moreno, R., Miranda, D. Reis, Fidler, V., Apolone, G., Sicignano, A., Carozzi, C., Giudici, D., Merli, G., Pulici, M., Gaillard, M., Emmanuelli, J., Hervé, C., Davous, H., Beck, D. H., Taylor, B. L., Smith, G. B., Paionk, F. G., Waydhas, C., Fischer, A., Duswald, K. H., Jiménez, M. J., del Nogal, F., Martín, A., Díaz, R., López, J., Suárez, J., Algora, A., Singer, M., Groeneveld, A. B. J., Bossink, A. W. K., Hack, C. E., Thijs, L. G., Mata, G. Vazquez, Fernandez, R. Rivera, Paeec, Proyecto, Schulze, K., Verner, Lj., Logemann, F., Kirchner, E., Garnacho-Montero, J., García-Garmendia, J. L., Ortiz-Leyba, C., Rincón-Ferrari, M. D., Villar, J. Monterrubio, Jiménez-Jiménez, F. J., Jiménez-Jiménez, L. M., Armaganidis, A., Dimitriadou, E., Kaltsas, P., Charisis, A., Pontikis, X., Roussos, Ch., Platsouka, E., Routsi, Ch., Markaki, V., Paniara, O., Young, J. D., Newton, B., Rowan, K., Jara, F., Naya, J. M., Cherta, I., Quíntana, S., Vázquez, P., Alvarez, M., Perez, J. Martinez, Garcia-Bach, M., Aparicio, A., Vila, F., Rué, M., Valero, C., Quintana, S., Artigas, A., Linde-Zwirble, W. T., Clermont, G., Coleman, M. B., Brodak, S., Angus, D. C., Dougnac, A., Hernandez, G., Ojeda, M., Castro, J., Labarca, E., Castillo, L., Andresen, M., Bugedo, G., Diaz, O., Arriagada, D., Dagnino, J., Pinsky, M. R., Newbold, R. C., Tampubolon, O. E., Iskandar, S., Siahaan, M., Suntoro, A., Albert, A., Fongaro, A., Carlot, A., Sattin, A., ARCHIDIA, and ICNARC Working Group on coding conditions in intensive care
- Published
- 1996
- Full Text
- View/download PDF
4. Rescue therapy with polymyxin B hemoperfusion in high-dose vasopressor therapy refractory septic shock
- Author
-
Monti, G., Terzi, V., Calini, A., fabiano di marco, Cruz, D., Pulici, M., Brioschi, P., Vesconi, S., Fumagalli, R., Casella, G., Monti, G, Terzi, V, Calini, A, Di Marco, F, Cruz, D, Pulici, M, Brioschi, P, Vesconi, S, Fumagalli, R, and Casella, G
- Subjects
Norepinephrine ,Hemoperfusion ,Septic ,Shock ,Gram-negative bacterial infections ,Multiple organ failure - Abstract
Background. Refractory septic shock (RSS) requiring major vasopressor support is associated with high mortality, especially in Gram-negative infections. The study aim was to describe hemodynamics, organ failure, and clinical outcomes in high-dose vasopressor therapy (HDVT) RSS patients treated with Polymyxin B hemoperfusion (PMX-HP) as rescue therapy. Methods. We retrospectively analyzed 52 patients, unresponsive to conventional therapy, treated with two sessions of PMX-HP requiring HDVT (norepinephrine and/or epinephrine requirement (NEP+EP) ≥0.5 μg/kg/min), ≥2 organ failures, and suspected/confirmed Gram-negative infection from any source. Results. At baseline, mean arterial pressure (MAP) was 80±13 mmHg and NEP+EP requirement was 1.11±0.56 μg/kg/min. After two PMX-HP sessions, at 72 h, MAP significantly increased and NEP+EP requirement decreased respectively by 12% and 76%. Pulmonary and renal function also improved significantly. Thirty patients (58%) showed a ≥50% reduction in NEP+EP dose within only 24 h after the first PMX-HP session (early responders), and 22 did not or died from irreversible shock in the same time frame (early non-responders). The 30-day hospital mortality was 29%; it was 16% in early responders and 45% in early non-responders. On multivariate analysis, SAPS II score, vasopressin, and central venous pressure significantly affected 30-day hospital mortality. Conclusion. This is the first study describing the use of PMX-HP as a rescue therapy in RSS patients with HDVT and MOF. Our results suggest a possible role for PMX-HP in improving hemodynamics, organ function, and mortality in RSS, with a 30-day survival of up to 70%.
- Published
- 2015
5. Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC)
- Author
-
Corona, A, Bertolini, G, Lipman, J, Wilson, Ap, Singer, M, Rodriguez, A, Cueto, G, Canales, Hs, Acosta Gnass, S, Marinoni, M, Becherucci, A, Baccaro, F, Peake, S, Reece, G, Blythe, D, Mcfayden, B, French, C, Hawker, F, Dobb, G, Seppelt, I, Finfer, S, Skowronski, G, Banerjee, A, Richards, B, Neumark, G, Hiesmayr, M, Rutraert, P, Franck, S, Spapen, H, Ludovic, L, Bruzzi de Carvalho, F, Souza, P, Gasparovic, V, Barsic, B, Chytra, I, Novak, I, Pestel, G, Kaiser, S, Giokas, G, Matamis, D, Yap Hiu Yi, F, Kapadia, F, Iqbal, M, Batoli, T, Costanzo, E, Pistocchini, A, Acquarolo, A, Greco, S, Di Masi, P, Quattrocchi, P, Navarra, M, Rotella, S, Giugiaro, P, Todesco, L, Borromeo, R, Ostando, M, Benassai, C, Pezzi, G, Marchi, M, Luise, C, Di Filippo, A, Mangani, V, Pelagatti, C, Pasetti, G, Salvi, G, Salcuni, R, Marongiu, A, Tavola, M, Rossi, G, Biffali, F, Brunori, E, Piccioni, G, Guadagnucci, A, David, Antonio, Pulici, M, Ughi, F, Sicignano, A, Leggieri, C, Fiore, G, Banfi, G, Lanza, S, Postiglione, M, Bosso, R, Piga, G, Croce, G, Sapuppo, Mf, Giarratano, A, Barbagallo, M, Favetta, P, Gorietti, A, Breschi, C, Andrei, O, Bertolini, R, Bonfà, A, Rossi, S, Asti, A, Rendina, F, Bilotta, F, Azzeri, F, Piacevoli, Q, Hellmann, F, Vaira, C, Avarello, N, Clementi, S, Della Valle, A, Segala, V, Berardino, M, Vaj, M, Sega, P, Bcchi, A, Pizzaballa, Ml, Cohen, J, Sprung, C, Hashimoto, S, Baskiene, R, Mcdonald, J, Sollid, S, Paiva, Ja, Moreno, R, Gloria, C, Yaghi, A, Voga, G, Joo Lee, Y, Zaragoza, R, Valles, J, Gonzalez Diaz, G, Alvarez Lerma, F, Sirvent, Jm, Herve, Z, Romand, Ja, Niblett, D, Laurenson, J, Peters, T, von der Osten, I, and Tomic, V.
- Subjects
Adult ,Male ,Microbiology (medical) ,medicine.medical_specialty ,Pediatrics ,Asia ,Critical Care ,medicine.drug_class ,Critical Illness ,Antibiotics ,Bacteremia ,Microbial Sensitivity Tests ,Outcome (game theory) ,Pharmacotherapy ,Intensive care ,Epidemiology ,medicine ,Humans ,Pharmacology (medical) ,Prospective Studies ,Antibiotic use ,Intensive care medicine ,bloodstream infections ,critically ill patients ,prevalence ,antibiotic strategy ,Aged ,Aged, 80 and over ,Pharmacology ,Australasia ,business.industry ,Septic shock ,Mortality rate ,Odds ratio ,Middle Aged ,South America ,medicine.disease ,Drug Utilization ,Confidence interval ,Anti-Bacterial Agents ,Europe ,Treatment Outcome ,Infectious Diseases ,Critical illness ,Female ,business ,Fungemia - Abstract
The lack of prospective, randomized, controlled trial data to guide optimal antibiotic use in bacteraemic critically ill patients has led to a wide variety of strategies and major issues with drug resistance. We therefore prospectively investigated the epidemiology of bacteraemia and fungaemia in intensive care units (ICUs); and the impact of timing, type and appropriateness of antibiotic intervention.We conducted a multinational, multicentre, prospective observational study in 132 ICUs from 26 countries with no interventions.1702 patients [European (69.6%), Australasian (12.2%), South American (8.3%) and Asian (9.9%)] developed 1942 bacteraemic episodes over the study period. Mortality rates were similar for those receiving empirical (40.5%), semi-targeted (37.6%) or fully targeted (33.3%) antibiotic therapy (P=0.40), and in those initially receiving broad- (39.3%) or restricted-spectrum (39.1%) therapy (P=0.94). First-line therapy was effective in terms of the antibiogram (where available) in 70.4% of cases. This in vitro susceptibility ranged from 76.3% for broad-spectrum antibiotics to 46.3% for restricted-spectrum antibiotics (P0.0001). However, no antibiotic policy-associated variable, including in vitro susceptibility (odds ratio 0.89, 95% confidence interval 0.61-1.30), was a statistically significant predictor of mortality.We could not show an impact of antibiotics on mortality in critically ill patients, despite in vitro activity and early commencement. Randomized, multicentre trials are urgently needed to establish the appropriate duration, timing and combinations of antibiotics that will both optimally treat infection and minimize development of resistance and other complications.
- Published
- 2010
- Full Text
- View/download PDF
6. External validation of the Simplified Acute Physiology Score (SAPS) 3 in a cohort of 28,357 patients from 147 Italian intensive care units
- Author
-
Poole, D, Rossi, C, Anghileri, A, Giardino, M, Latronico, N, Radrizzani, D, Langer, M, Bertolini, G, Acciarri, C, Acquarolo, A, Adorni, A, Alberti, A, Alborghetti, A, Antonini, B, Archi, D, Arditi, E, Badii, F, Balata, A, Barattini, M, Barbagli, R, Barbieri, P, Baroncia, M, Bartoccini, A, Bartoli, T, Bassi, F, Beck, E, Bellato, V, Bellorini, M, Belluomo Anello, C, Benanti, C, Berardino, M, Bernasconi, Mo, Besozzi, A, Bianchin, A, Bindi, Ml, Biolino, P, Blasetti, A, Boccalatte, D, Bonaccorso, G, Bonfà, A, Bonfiglio, M, Boniotti, C, Bonizzoli, M, Bottari, V, Breschi, C, Brunori, E, Buonanno, R, Buzzetti, V, Calicchio, G, Calva, S, Capannolo, B, Caracciolo, A, Carnevale, L, Carsana, C, Casadei, E, Casagli, S, Casagrande, L, Casalini, P, Castiglione, G, Cavallo, R, Chiarello, M, Chieregato, A, Chinelli, E, Cigada, M, Coaloa, M, Colombo, R, Colombo, S, Corsini, W, Corvi, D, Cosentino, E, Costa, R, Costanzo, E, Cottignoli, T, Crema, L, Crestan, E, Da Re, D, Dal Cero, P, Dal Ferro, M, David, Antonio, De Blasi RA, De Blasio, E, De Luca, A, De Negri, P, Dei Poli, M, Del Sarto, P, Di Lorenzo, G, Di Masi, P, Di Pasquale, D, Di Serafino, G, Donato, I, Fabbri, L, Fabbri, E, Fabbri, Pg, Fabi, Mc, Faccio, L, Ferla, F, Ferri, F, Fiore, G, Fognani, G, Galeotti, E, Gamberini, E, Garelli, A, Garofalo, G, Garzilli, T, Giacopuzzi, L, Gianni, M, Giannoni, S, Giugiaro, Pm, Gorietti, A, Grassi, P, Greco, M, Guadagnucci, A, Guagliardi, C, Isetta, M, Lapolla, A, Lefons, U, Livigni, S, Madonna, R, Maestrone, C, Magatti, Mf, Maggiolo, C, Malacarne, P, Mancosu, S, Mangani, Va, Mantovani, G, Marafon, S, Martinez Escobar, R, Mastroianni, A, Mastropierro, R, Meloni, A, Messina, M, Miglioranzi, R, Molino, Fm, Morigi, A, Mosca, C, Murri, V, Nardi, G, Nascimben, E, Natalini, G, Negri, G, Negro, G, Neri, M, Nicolini, A, Nuovo, D, Odetto, L, Olivieri, C, Ortoleva, A, Pacini, Dm, Paganini, G, Paganoni, G, Palmer, M, Papiri, S, Parma, A, Parrini, V, Pastorelli, M, Pastorini, S, Pegoraro, M, Pezzi, A, Pinciroli, D, Piredda, G, Piva, S, Pizzaballa, M, Possamai, C, Postiglione, M, Potalivo, A, Pulici, M, Quattrocchi, P, Raffaeli, M, Ranzini, L, Righini, E, Rona, R, Rossi, G, Rossi, S, Rossi, M, Rottoli, F, Salcuni, R, Salvi, G, Savioli, M, Scarrone, S, Schellino, Mm, Segala, V, Segalini, Pa, Sera, G, Sforza, D, Sicignano, A, Sorbara, C, Spadini, E, Staccioli, P, Stefani, M, Sucre, Mj, Tartari, S, Tavola, M, Tetamo, R, Tibaldi, G, Tinacci, S, Todesco, L, Torta, M, Tosi, L, Tripepi, C, Ughi, L, Vaj, M, Vecchiarelli, P, Vespignani, Mg, Visconti, Mg, Vulcano, Ga, Zappa, S, Zocaro, R, and Zuccaro, F.
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,genetic structures ,Critical Care ,Critical Illness ,Critical Care and Intensive Care Medicine ,law.invention ,Bias ,law ,Predictive Value of Tests ,Risk Factors ,Intensive care ,Anesthesiology ,Outcome Assessment, Health Care ,medicine ,Humans ,Hospital Mortality ,Prospective Studies ,Simplified Acute Physiology Score ,Intensive care medicine ,Prospective cohort study ,Diagnosis-Related Groups ,APACHE ,Aged ,Chi-Square Distribution ,business.industry ,Data Collection ,Benchmarking ,Critical care ,Hospital mortality ,Outcome assessment ,Validation study ,Discriminant Analysis ,Middle Aged ,Prognosis ,Intensive care unit ,Intensive Care Units ,Logistic Models ,Italy ,ROC Curve ,Predictive value of tests ,Cohort ,Calibration ,Female ,business ,Chi-squared distribution - Abstract
To evaluate the SAPS 3 score predictive ability of hospital mortality in a large external validation cohort.Prospective observational study.A total of 28,357 patients from 147 Italian ICUs joining the Project Margherita national database of the Gruppo italiano per la Valutazione degli interventi in Terapia Intensiva (GiViTI).None.Evaluation of discrimination through ROC analysis and of overall goodness-of-fit through the Cox calibration test.Although discrimination was good, calibration turned out to be poor. The general and the South-Europe Mediterranean countries equations overestimated hospital mortality overall (SMR values 0.73 with 95% CI 0.72-0.75 for both equations) and homogeneously across risk classes. Overprediction was confirmed among important subgroups, with SMR values ranging between 0.47 and 0.82.The result strictly supported by our data is that the SAPS 3 score calibrates inadequately in a large sample of Italian ICU patients and thus should not be used for benchmarking, at least in Italian settings.
- Published
- 2009
7. 3-Aminopyrazole Inhibitors of CDK2/Cyclin A as Anti-Tumor Agents: Part 1. Lead Finding
- Author
-
Pevarello, P., Brasca, G., Amici, R., Orsini, P., Traquandi, G., Corti, L., Piutti, C., Sansonna, P., Villa, M., Pierce, B. S., Pulici, M., Giordano, P., Martina, Katia, Fritzen, E. L., Nugent, R. A., Casale, E., Cameron, A., Ciomei, M., Roletto, F., Isacchi, A., Fogliatto, G., Pesenti, E., Pastori, W., Marsiglio, A., Leach, K. L., Clare, P. M., Fiorentini, F., Varasi, M., Vulpetti, A., and Warpehosky, M. A.
- Published
- 2004
8. B-Raf Kinase V600E mutant in complex with a diarylthiazole B-Raf Inhibitor
- Author
-
Casale, E., primary, Fasolini, M., additional, Pulici, M., additional, Traquandi, G., additional, Marchionni, C., additional, Modugno, M., additional, Lupi, R., additional, Amboldi, N., additional, Colombo, N., additional, Corti, L., additional, Gasparri, F., additional, Pastori, W., additional, Scolaro, A., additional, Donati, D., additional, Felder, E., additional, Galvani, A., additional, Isacchi, A., additional, Pesenti, E., additional, and Ciomei, M., additional
- Published
- 2014
- Full Text
- View/download PDF
9. AURORA-A T288E COMPLEXED WITH PHA-828300
- Author
-
Bindi, S., primary, Fancelli, D., additional, Alli, C., additional, Berta, D., additional, Bertrand, J.A., additional, Cameron, A.D., additional, Cappella, P., additional, Carpinelli, P., additional, Cervi, G., additional, Croci, W., additional, D'Anello, M., additional, Forte, B., additional, LauraGiorgini, M., additional, Marsiglio, A., additional, Moll, J., additional, Pesenti, E., additional, Pittala, V., additional, Pulici, M., additional, Riccardi-Sirtori, F., additional, Roletto, F., additional, Soncini, C., additional, Storici, P., additional, Varasi, M., additional, Volpi, D., additional, Zugnoni, P., additional, and Vianello, P., additional
- Published
- 2010
- Full Text
- View/download PDF
10. ChemInform Abstract: Studies Toward a Model for the Prediction of the Regioselectivity in the Fischer Indole Synthesis
- Author
-
PULICI, M., primary and SELLO, G., additional
- Published
- 2010
- Full Text
- View/download PDF
11. ChemInform Abstract: Metabolites of Endophytic Fungi of Taxus brevifolia: The First Highly Functionalized Humulane of Fungal Origin.
- Author
-
PULICI, M., primary, SUGAWARA, F., additional, KOSHINO, H., additional, UZAWA, J., additional, and YOSHIDA, S., additional
- Published
- 2010
- Full Text
- View/download PDF
12. Bioreactance versus PICCOTD/PC in critically ill septic shock patients
- Author
-
Monti, G, primary, Pizzilli, G, additional, Cecconi, M, additional, Rhodes, A, additional, Vesconi, S, additional, Brioschi, P, additional, Pulici, M, additional, and Casella, G, additional
- Published
- 2010
- Full Text
- View/download PDF
13. Structure of CDK2/Cyclin A with PNU-292137
- Author
-
Pevarello, P., primary, Brasca, M.G., additional, Amici, R., additional, Orsini, P., additional, Traquandi, G., additional, Corti, L., additional, Piutti, C., additional, Sansonna, P., additional, Villa, M., additional, Pierce, B.S., additional, Pulici, M., additional, Giordano, P., additional, Martina, K., additional, Fritzen, E.L., additional, Nugent, R.A., additional, Casale, E., additional, Cameron, A., additional, Ciomei, M., additional, Roletto, F., additional, Isacchi, A., additional, Fogliatto, G., additional, Pesenti, E., additional, Pastori, W., additional, Marsiglio, A., additional, Leach, K.L., additional, Clare, P.M., additional, Fiorentini, F., additional, Varasi, M., additional, Vulpetti, A., additional, and Warpehoski, M.A., additional
- Published
- 2004
- Full Text
- View/download PDF
14. Use of Multicomponent, Domino, and Other One‐pot Syntheses on Solid Phase: Powerful Tools for the Generation of Libraries of Diverse and Complex Compounds
- Author
-
Pulici, M., primary, Cervi, G., additional, Martina, K., additional, and Quartieri, F., additional
- Published
- 2004
- Full Text
- View/download PDF
15. Use of Multicomponent, Domino, and Other One-Pot Syntheses on Solid Phase: Powerful Tools for the Generation of Libraries of Diverse and Complex Compounds
- Author
-
Pulici, M., primary, Cervi, G., additional, Martina, K., additional, and Quartieri, F., additional
- Published
- 2003
- Full Text
- View/download PDF
16. ChemInform Abstract: Pestalotiopsins A and B: New Caryophyllenes from an Endophytic Fungus of Taxus brevifolia.
- Author
-
PULICI, M., primary, SUGAWARA, F., additional, KOSHINO, H., additional, UZAWA, J., additional, YOSHIDA, S., additional, LOBKOVSKY, E., additional, and CLARDY, J., additional
- Published
- 1996
- Full Text
- View/download PDF
17. Studies toward a model for the prediction of the regioselectivity in the Fischer indole synthesis
- Author
-
Pulici, M., primary and Sello, G., additional
- Published
- 1993
- Full Text
- View/download PDF
18. Trifluoroacetic Anhydride-Mediated Solid-Phase Version of the Robinson−Gabriel Synthesis of Oxazoles
- Author
-
Pulici, M., Quartieri, F., and Felder, E. R.
- Abstract
A traceless solid-phase synthesis of oxazoles
4 via Robinson−Gabriel reaction of solid-supported α-acylamino ketones2 has been achieved. The reaction requires that the cyclization precursor be linked to a benzhydrylic-type linker (compounds2 ) and that trifluoroacetic anhydride be used as the cyclodehydrating agent. The solvent has a dramatic effect on the latter reaction, which goes to completion and follows a cyclative-type mechanism only when an ethereal solvent is used. Different synthetic routes have been investigated toward assembling compounds2 . The most straightforward one, which we have validated more extensively, comprises the reaction of Merrifield α-methoxyphenyl (MAMP) resin with an α-amino ketone to form compounds1 , which are, in turn, acylated. Other methodologies and strategies allowing for the synthesis of compounds1 that have been investigated include direct alkylation of Rink amide resin; reductive amination of the latter with α-keto aldehydes; reaction of MAMP resin with α-amino alcohols, followed by oxidation; and protection of Rink amide resin with either 2,4-dinitrosulfonyl or allyl group, followed by alkylation and removal of protecting group. In addition, we disclose a novel variant of the Ugi four-component reaction that allows for the preparation of compounds2 in a single synthetic step.- Published
- 2005
19. 3-Aminopyrazole Inhibitors of CDK2/Cyclin A as Antitumor Agents. 1. Lead Finding
- Author
-
Pevarello, P., Brasca, M. G., Amici, R., Orsini, P., Traquandi, G., Corti, L., Piutti, C., Sansonna, P., Villa, M., Pierce, B. S., Pulici, M., Giordano, P., Martina, K., Fritzen, E. L., Nugent, R. A., Casale, E., Cameron, A., Ciomei, M., Roletto, F., Isacchi, A., Fogliatto, G., Pesenti, E., Pastori, W., Marsiglio, A., Leach, K. L., Clare, P. M., Fiorentini, F., Varasi, M., Vulpetti, A., and Warpehoski, M. A.
- Abstract
Abnormal proliferation mediated by disruption of the normal cell cycle mechanisms is a hallmark of virtually all cancer cells. Compounds targeting complexes between cyclin-dependent kinases (CDK) and cyclins, such as CDK2/cyclin A and CDK2/cyclin E, and inhibiting their kinase activity are regarded as promising antitumor agents to complement the existing therapies. From a high-throughput screening effort, we identified a new class of CDK2/cyclin A/E inhibitors. The hit-to-lead expansion of this class is described. X-ray crystallographic data of early compounds in this series, as well as in vitro testing funneled for rapidly achieving in vivo efficacy, led to a nanomolar inhibitor of CDK2/cyclin A (N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(2-naphthyl)acetamide (
41) , PNU-292137, IC50 = 37 nM) with in vivo antitumor activity (TGI > 50%) in a mouse xenograft model at a dose devoid of toxic effects.- Published
- 2004
20. Metabolites of Pestalotiopsis spp., endophytic fungi of Taxus brevifolia
- Author
-
Pulici, M., Sugawara, F., Koshino, H., Okada, G., Esumi, Y., Uzawa, J., and Yoshida, S.
- Published
- 1997
- Full Text
- View/download PDF
21. ISOLATION OF A NEW COMPOUND RELATED TO 4-METHOXYPYRIDOXINE FROM ALBIZZIA-LUCIDA
- Author
-
Fulvia Orsini, Pelizzoni, F., Pulici, M., and Verotta, L.
22. ChemInform Abstract: Isolation of a New Compound (I) Related to 4‐Methoxypyridoxine from Albizzia lucida.
- Author
-
ORSINI, F., primary, PELIZZONI, F., additional, PULICI, M., additional, and VEROTTA, L., additional
- Published
- 1989
- Full Text
- View/download PDF
23. A New Isodrimeninol from Pestalotiopsis sp.
- Author
-
Pulici, M., Sugawara, F., Koshino, H., Uzawa, J., Yoshida, S., Lobkovsky, E., and Clardy, J.
- Abstract
A new sesquiterpene 2α-hydroxydimeninol
1 was isolated as the most polar metabolite produced by a cultured Pestalotiopsis sp., a fungus associated with Taxus sp. Its structure was established by spectroscopic and X-ray diffraction analyses.- Published
- 1996
24. ChemInform Abstract: Metabolites of Endophytic Fungi of Taxus brevifolia: The First Highly Functionalized Humulane of Fungal Origin.
- Author
-
PULICI, M., SUGAWARA, F., KOSHINO, H., UZAWA, J., and YOSHIDA, S.
- Published
- 1996
- Full Text
- View/download PDF
25. ChemInform Abstract: Studies Toward a Model for the Prediction of the Regioselectivity in the Fischer Indole Synthesis.
- Author
-
PULICI, M. and SELLO, G.
- Published
- 1993
- Full Text
- View/download PDF
26. Low-valent complexes of cobalt and phosphorus donor ligands as mediators in Reformatsky-type reactions
- Author
-
Orsini, F., Pulici, M., and Vallarino, L. M.
- Published
- 1995
- Full Text
- View/download PDF
27. Visible Light Promoted Site-Specific Functionalization of α-Acyloxy Carboxamides: Unlocking a Forbidden Chemical Space in the Passerini Reaction.
- Author
-
Brunelli F, Quartieri F, Miletto I, Pulici M, Papeo G, and Tron GC
- Abstract
The facile generation of the α-acyloxy carboxamide radical is hereby reported for the first time, utilizing a photoredox catalyzed reaction of Passerini adducts synthesized using a 4-formyl-1,4-dihydropyridine as the carbonyl component. This radical effectively engages in a Giese reaction with a range of olefins, ultimately leading to the synthesis of novel Passerini-derived products not previously amenable to direct aldehyde-based transformations. Consequently, the resulting strategy, developed both in batch and in flow, offers a promising opportunity to expand the chemical space accessible through the Passerini reaction, virtually incorporating "impossible" aldehydes., (© 2024 Wiley-VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
28. Current concepts of perioperative monitoring in high-risk surgical patients: a review.
- Author
-
Aseni P, Orsenigo S, Storti E, Pulici M, and Arlati S
- Abstract
A substantial number of patients are at high-risk of intra- or post-operative complications or both. Most perioperative deaths are represented by patients who present insufficient physiological reserve to meet the demands of major surgery. Recognition and management of critical high-risk surgical patients require dedicated and effective teams, capable of preventing, recognize, start treatment with adequate support in time to refer patients to the satisfactory ICU level provision. The main task for health-care planners and managers is to identify and reduce this severe risk and to encourage patient's safety practices. Inadequate tissue perfusion and decreased cellular oxygenation due to hypovolemia, heart dysfunction, reduced cardiovascular reserve, and concomitant diseases are the most common causes of perioperative complications. Hemodynamic, respiratory and careful sequential monitoring have become essential aspects of the clinical practice both for surgeons and intensivists. New monitoring techniques have changed significantly over the past few years and are now able to rapidly identify shock states earlier, define the etiology, and monitor the response to different therapies. Many of these techniques are now minimally invasive or non-invasive. Advanced hemodynamic and respiratory monitoring combines invasive, non-invasive monitoring skills. Non-invasive ultrasound has emerged during the last years as an essential operative and perioperative evaluation tool, and its use is now rapidly growing. Perioperative management guided by appropriate sequential clinical evaluation combined with respiratory and hemodynamic monitoring is an established tool to help clinicians to identify those patients at higher risk in the attempt to reduce the complications rate and potentially improve patient outcomes. This review aims to provide an update of currently available standard concepts and evolving technologies of the various respiratory and hemodynamic monitoring systems for the high-risk surgical patients, highlighting their potential usefulness when integrated with careful clinical evaluation., Competing Interests: Competing interestsNone of the authors have any conflicts of interests to declare. The authors received no pharmaceutical or industrial support for this study. No further direct or indirect financial support or other assets were transferred to the authors or their family members for this study., (© The Author(s). 2019.)
- Published
- 2019
- Full Text
- View/download PDF
29. Rescue therapy with polymyxin B hemoperfusion in high-dose vasopressor therapy refractory septic shock.
- Author
-
Monti G, Terzi V, Calini A, Di Marco F, Cruz D, Pulici M, Brioschi P, Vesconi S, Fumagalli R, and Casella G
- Subjects
- Adult, Aged, Anti-Bacterial Agents administration & dosage, Drug Resistance, Epinephrine administration & dosage, Epinephrine therapeutic use, Female, Hemoperfusion, Hospital Mortality, Humans, Male, Middle Aged, Multiple Organ Failure etiology, Multiple Organ Failure mortality, Norepinephrine administration & dosage, Norepinephrine therapeutic use, Polymyxin B administration & dosage, Retrospective Studies, Shock, Septic mortality, Shock, Septic physiopathology, Vasoconstrictor Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Polymyxin B therapeutic use, Shock, Septic drug therapy, Vasoconstrictor Agents therapeutic use
- Abstract
Background: Refractory septic shock (RSS) requiring major vasopressor support is associated with high mortality, especially in Gram-negative infections. The study aim was to describe hemodynamics, organ failure, and clinical outcomes in high-dose vasopressor therapy (HDVT) RSS patients treated with Polymyxin B hemoperfusion (PMX-HP) as rescue therapy., Methods: We retrospectively analyzed 52 patients, unresponsive to conventional therapy, treated with two sessions of PMX-HP requiring HDVT (norepinephrine and/or epinephrine requirement (NEP+EP) ≥ 0.5 µg/kg/min), ≥ 2 organ failures, and suspected/confirmed Gram-negative infection from any source., Results: At baseline, mean arterial pressure (MAP) was 80 ± 13 mmHg and NEP + EP requirement was 1.11 ± 0.56 µg/kg/min. After two PMX-HP sessions, at 72 h, MAP significantly increased and NEP + EP requirement decreased respectively by 12% and 76%. Pulmonary and renal function also improved significantly. Thirty patients (58%) showed a ≥ 50% reduction in NEP + EP dose within only 24 h after the first PMX-HP session (early responders), and 22 did not or died from irreversible shock in the same time frame (early non-responders). The 30-day hospital mortality was 29%; it was 16% in early responders and 45% in early non-responders. On multivariate analysis, SAPS II score, vasopressin, and central venous pressure significantly affected 30-day hospital mortality., Conclusion: This is the first study describing the use of PMX-HP as a rescue therapy in RSS patients with HDVT and MOF. Our results suggest a possible role for PMX-HP in improving hemodynamics, organ function, and mortality in RSS, with a 30-day survival of up to 70%.
- Published
- 2015
30. Cell Proliferation Method: Click Chemistry Based on BrdU Coupling for Multiplex Antibody Staining.
- Author
-
Cappella P, Gasparri F, Pulici M, and Moll J
- Subjects
- Animals, Cell Proliferation, Cycloaddition Reaction, DNA metabolism, Deoxyuridine analogs & derivatives, Deoxyuridine metabolism, Flow Cytometry, Fluorescent Antibody Technique, Humans, Mice, Inbred BALB C, Antibodies metabolism, Bromodeoxyuridine metabolism, Click Chemistry methods, Staining and Labeling
- Abstract
Determination of incorporation of the thymidine analog 5-bromo-2'-deoxyuridine (BrdU) into DNA is a widely used method to analyze the cell cycle. However, DNA denaturation is required for BrdU detection with the consequence that most protein epitopes are destroyed and their immunocytochemical detection for multiplex analysis is not possible. A novel assay is presented for identifying cells in active S-phase that does not require the DNA denaturation step but nevertheless detects BrdU. For this purpose, cells were pulsed for a short time by 5-ethynyl-2'-deoxyuridine (EdU) which is incorporated into DNA. The nucleotide-exposed ethynyl residue was then derivatized by a copper-catalyzed cycloaddition reaction ("click chemistry" coupling) using a BrdU azide probe. The resulting DNA-bound bromouracil moieties were then detected by commercial anti-BrdU monoclonal antibodies without the need for a denaturation step. This method has been tested using several cell lines and is more sensitive than traditional BrdU and allows multicolor and multiplex analysis in flow cytometry (FCM) and image-based cytometry., (Copyright © 2015 John Wiley & Sons, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
31. Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effect.
- Author
-
Pulici M, Traquandi G, Marchionni C, Modugno M, Lupi R, Amboldi N, Casale E, Colombo N, Corti L, Fasolini M, Gasparri F, Pastori W, Scolaro A, Donati D, Felder E, Galvani A, Isacchi A, Pesenti E, and Ciomei M
- Subjects
- Administration, Oral, Animals, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Binding Sites, Cell Line, Tumor, Cell Proliferation drug effects, ERG1 Potassium Channel, Ether-A-Go-Go Potassium Channels antagonists & inhibitors, Ether-A-Go-Go Potassium Channels metabolism, Humans, MAP Kinase Kinase 1 genetics, MAP Kinase Kinase 1 metabolism, Mice, Mice, Inbred BALB C, Mice, Nude, Phosphorylation drug effects, Protein Binding, Protein Kinase Inhibitors pharmacology, Protein Kinase Inhibitors therapeutic use, Protein Structure, Tertiary, Proto-Oncogene Proteins B-raf genetics, Proto-Oncogene Proteins B-raf metabolism, Sulfonamides therapeutic use, Sulfonamides toxicity, Thiazoles pharmacology, Thiazoles therapeutic use, Thiazoles toxicity, Transplantation, Heterologous, Antineoplastic Agents chemistry, Protein Kinase Inhibitors chemistry, Proto-Oncogene Proteins B-raf antagonists & inhibitors, Sulfonamides chemistry, Thiazoles chemistry
- Abstract
Aberrant activation of the mitogen-activated protein kinase (MAPK)-mediated pathway components, RAF-MEK-ERK, is frequently observed in human cancers and clearly contributes to oncogenesis. As part of a project aimed at finding inhibitors of B-Raf, a key player in the MAPK cascade, we originally identified a thiazole derivative endowed with high potency and selectivity, optimal in vitro ADME properties, and good pharmacokinetic profiles in rodents, but that suffers from elevated hERG inhibitory activity. An optimization program was thus undertaken, focused mainly on the elaboration of the R(1) and R(2) groups of the scaffold. This effort ultimately led to N-(4-{2-(1-cyclopropylpiperidin-4-yl)-4-[3-(2,5-difluorobenzenesulfonylamino)-2-fluorophenyl]thiazol-5-yl}-pyridin-2-yl)acetamide (20), which maintains favorable in vitro and in vivo properties, but lacks hERG liability. Besides exhibiting potent antiproliferative activity against only cell lines bearing B-Raf V600E or V600D mutations, compound 20 also intriguingly shows a weaker "paradoxical" activation of MEK in non-mutant B-Raf cells than other known B-Raf inhibitors. It also demonstrates very good efficacy in vivo against the A375 xenograft melanoma model (tumor volume inhibition >90% at 10 mg kg(-1) ); it is therefore a suitable candidate for preclinical development., (© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2015
- Full Text
- View/download PDF
32. Application of click chemistry conditions for 5-bromo-2'-deoxyuridine determination through Fenton and related reactions.
- Author
-
Cappella P, Pulici M, and Gasparri F
- Subjects
- Catalysis, Cell Line, Tumor, Cell Proliferation, DNA metabolism, Deoxyuridine analogs & derivatives, Flow Cytometry, Humans, Immunohistochemistry, Staining and Labeling, Bromodeoxyuridine metabolism, Click Chemistry methods, Hydrogen Peroxide metabolism, Iron metabolism
- Abstract
Mixtures of ascorbate and copper used in certain click chemistry experimental conditions act as oxidizing agents, catalyzing the formation of reactive oxygen species through Fenton and related reactions. Hydroxyl radicals act as chemical nucleases, introducing DNA strand breaks that can be exploited for BrdU immunostaining in place of acid denaturation. This procedure is readily applicable to high content analysis and flow cytometry assays, and provides results comparable to click chemistry EdU cycloaddition and classical BrdU immunodetection. Importantly, this approach allows preservation of labile epitopes such as phosphoproteins. This unit describes an optimized method that successfully employs Fenton chemistry for simultaneous detection of phosphoproteins and BrdU in intact cells., (Copyright © 2015 John Wiley & Sons, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
33. From "Click" to "Fenton" chemistry for 5-bromo-2'-deoxyuridine determination.
- Author
-
Cappella P, Giansanti V, Pulici M, and Gasparri F
- Subjects
- Cell Line, Cell Proliferation drug effects, Click Chemistry, DNA chemistry, DNA isolation & purification, DNA Replication genetics, Humans, Staining and Labeling, Ascorbic Acid chemistry, Bromodeoxyuridine chemistry, DNA biosynthesis, Flow Cytometry methods
- Abstract
Ascorbic acid (AA) and copper have been increasingly employed in flow cytometry (FCM) and high content analysis (HCA) since the introduction of "click chemistry" as a non-destructive alternative to classical 5-bromo-2'-deoxyuridine (BrdU) immunodetection for DNA synthesis and proliferation assays. Mixtures of ascorbate and catalytic copper, under certain experimental conditions, act as oxidizing agent, catalyzing the formation of reactive hydroxyl radicals through hydrogen peroxides decomposition via Fenton reaction. We developed a procedure for BrdU incorporation detection based on the use of AA and cupric ions as DNA damaging agents. Optimal DNA damaging conditions were identified and found to provide results comparable with "click" 5-ethynyl-deoxyuridine (EdU) cycloaddition approach and classical BrdU immunodetection. Scavenger agents were found to prevent hydroxyl-induced DNA damages, providing the proof-of-concept for the use of this procedure for DNA denaturation prior to BrdU detection. We demonstrated hydroxyl radicals' reaction to be readily applicable to HCA and FCM assays, for both classical BrdU immunostaining and EdU cycloaddition procedure. This technique was successfully employed for BrdU pulse-chase experiments and in multiparametric immunofluorescence assays for the simultaneous detection of labile phosphoproteins in intact cells. The use of AA/Cu prior to immunodetection for BrdU incorporation assays is a viable alternative to chemical/physical DNA denaturing agents (acids or heat), since it allows preservation of labile epitopes such as phosphoproteins, and over enzymatic agents (digestion with DNases) for its lower cost., (© 2013 International Society for Advancement of Cytometry.)
- Published
- 2013
- Full Text
- View/download PDF
34. Italian chemists' contributions to named reactions in organic synthesis: an historical perspective.
- Author
-
Papeo G and Pulici M
- Subjects
- Catalysis, History, 19th Century, History, 20th Century, History, 21st Century, Humans, Italy, Photochemical Processes, Chemistry Techniques, Synthetic history, Chemistry, Organic history
- Abstract
From the second half of the 19th century up to modern times, the tremendous contribution of Italian chemists to the development of science resulted in the discovery of a number of innovative chemical transformations. These reactions were subsequently christened according to their inventors' name and so entered into the organic chemistry portfolio of "named organic reactions". As these discoveries were being conceived, massive social, political and geographical changes in these chemists' homeland were also occurring. In this review, a brief survey of known (and some lesser known) named organic reactions discovered by Italian chemists, along with their historical contextualization, is presented.
- Published
- 2013
- Full Text
- View/download PDF
35. From polymer to small organic molecules: a tight relationship between radical chemistry and solid-phase organic synthesis.
- Author
-
Mirizzi D and Pulici M
- Subjects
- Indicators and Reagents chemistry, Organic Chemicals chemistry, Polymers chemistry
- Abstract
Since Gomberg's discovery of radicals as chemical entities, the interest around them has increased through the years. Nowadays, radical chemistry is used in the synthesis of 75% of all polymers, inevitably establishing a close relationship with Solid-Phase Organic Synthesis. More recently, the interest of organic chemists has shifted towards the application of usual "in-solution" radical chemistry to the solid-phase, ranging from the use of supported reagents for radical reactions, to the development of methodologies for the synthesis of small molecules or potential libraries. The aim of this review is to put in perspective radical chemistry, moving it away from its origin as a synthetic means for solid supports, to becoming a useful tool for the synthesis of small molecules.
- Published
- 2011
- Full Text
- View/download PDF
36. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
- Author
-
Bindi S, Fancelli D, Alli C, Berta D, Bertrand JA, Cameron AD, Cappella P, Carpinelli P, Cervi G, Croci V, D'Anello M, Forte B, Giorgini ML, Marsiglio A, Moll J, Pesenti E, Pittalà V, Pulici M, Riccardi-Sirtori F, Roletto F, Soncini C, Storici P, Varasi M, Volpi D, Zugnoni P, and Vianello P
- Subjects
- Animals, Antineoplastic Agents chemistry, Aurora Kinases, Cell Cycle drug effects, Cell Proliferation drug effects, Computational Biology, Crystallography, X-Ray, Drug Screening Assays, Antitumor, Enzyme Inhibitors chemistry, HL-60 Cells, Humans, Male, Mice, Mice, SCID, Models, Molecular, Molecular Dynamics Simulation, Molecular Structure, Neoplasms, Experimental drug therapy, Pyrazoles chemical synthesis, Pyrazoles chemistry, Stereoisomerism, Structure-Activity Relationship, Thiophenes chemical synthesis, Thiophenes chemistry, Transplantation, Heterologous, Antineoplastic Agents chemical synthesis, Antineoplastic Agents pharmacology, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors pharmacology, Protein Serine-Threonine Kinases antagonists & inhibitors, Pyrazoles pharmacology, Thiophenes pharmacology
- Abstract
A novel series of 3-amino-1H-thieno[3,2-c]pyrazole derivatives demonstrating high potency in inhibiting Aurora kinases was developed. Here we describe the synthesis and a preliminary structure-activity relationship, which led to the discovery of a representative compound (38), which showed low nanomolar inhibitory activity in the anti-proliferation assay and was able to block the cell cycle in HCT-116 cell line. This compound demonstrated favorable pharmacokinetic properties and good efficacy in the HL-60 xenograft tumor model., (Copyright © 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
37. A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining.
- Author
-
Cappella P, Gasparri F, Pulici M, and Moll J
- Subjects
- Animals, Antibodies chemistry, Bone Marrow Cells cytology, Caspase 3 metabolism, Cell Cycle, Deoxyuridine pharmacology, HL-60 Cells, Histones chemistry, Humans, Male, Mice, Mice, Inbred BALB C, Models, Biological, Bromodeoxyuridine pharmacology, Deoxyuridine analogs & derivatives, Flow Cytometry methods
- Abstract
Quantification of BrdU incorporation into DNA is a widely used technique to assess the cell cycle status of cells. DNA denaturation is required for BrdU detection with the drawback that most protein epitopes are destroyed and classical antibody staining techniques for multiplex analysis are not possible. To address this issue we have developed a novel method that overcomes the DNA denaturation step but still allows detection of BrdU. Cells were pulsed for a short time by 5-ethynyl-2'-deoxyuridine, which is incorporated into DNA. The exposed nucleotide alkyne group of DNA was then derivatized in physiologic conditions by the copper (I)-catalyzed azide-alkyne cycloaddition (CuAAC) using BrdU azides. The resulting DNA-bound bromouracil moiety was subsequently detected by commercial anti-BrdU mAb without the need for a denaturation step. Continuous labeling with EdU showed a slightly increased anti-proliferative activity compared to BrdU. However, using a lower concentration of EdU for labeling can compensate for this. Alkynyl tags could be detected quickly by a highly specific reaction using BrdU azides. Fluorescence quenching by the DNA dye PI using both BrdU azides was negligible. Our labeling method is suitable for FCM and HCA and shows a higher signal to noise ratio than other methods. This method also allowed multiplex analysis by simultaneous detection of EdU-BrdU, caspase-3, and phospho-histone 3 mAbs, proving sensitivity and feasibility of this new technique. In addition, it has the potential for use in vivo, as exemplified for bone marrow studies. We have established a new method to determine the position of cells in the cell cycle. This is superior when compared to traditional BrdU detection since it allows multiplex analysis, is more sensitive and shows less quenching with PI. The method provides new opportunities to investigate changes in protein expression at different cell cycle stages using pulse labeling experiments., ((c) 2008 International Society for Advancement of Cytometry)
- Published
- 2008
- Full Text
- View/download PDF
38. Cell proliferation method: click chemistry based on BrdU coupling for multiplex antibody staining.
- Author
-
Cappella P, Gasparri F, Pulici M, and Moll J
- Subjects
- Bromodeoxyuridine chemistry, Bromodeoxyuridine immunology, DNA chemistry, Methods, S Phase, Antibodies, Monoclonal, Bromodeoxyuridine analysis, Cell Proliferation, DNA analysis, Flow Cytometry methods, Staining and Labeling methods
- Abstract
Determination of incorporation of the thymidine analog 5-bromo-2'-deoxyuridine (BrdU) into DNA is a widely used method to analyze the cell cycle (see UNIT 7.7). However, DNA denaturation is required for BrdU detection with the consequence that most protein epitopes are destroyed and their immunocytochemical detection for multiplex analysis is not possible. A novel assay is presented for identifying cells in active S-phase that does not require the DNA denaturation step but nevertheless detects BrdU. For this purpose, cells were pulsed for a short time by an alkenyl deoxyuridine (5-ethynyl-2'-deoxyuridine, EdU), which is incorporated into DNA. The nucleotide exposed ethynyl residue was then derivatized by a copper-catalyzed cycloaddition reaction ("click chemistry" coupling) using a BrdU azide probe. The resulting DNA-bound bromouracil moieties were then detected by commercial anti-BrdU monoclonal antibodies without the need for a denaturation step. This method has been tested using several cell lines and is preferred over traditional BrdU detection since it is more sensitive and allows multicolor and multiplex analysis in FCM and imaging.
- Published
- 2008
- Full Text
- View/download PDF
39. Trifluoroacetic anhydride-mediated solid-phase version of the Robinson-Gabriel synthesis of oxazoles.
- Author
-
Pulici M, Quartieri F, and Felder ER
- Subjects
- Acetic Anhydrides, Acylation, Amides chemistry, Amination, Amines chemistry, Amino Alcohols chemistry, Cyclization, Ketones chemistry, Models, Chemical, Oxidation-Reduction, Resins, Synthetic chemistry, Time Factors, Combinatorial Chemistry Techniques, Fluoroacetates, Oxazoles chemical synthesis, Technology, Pharmaceutical, Trifluoroacetic Acid chemistry
- Abstract
A traceless solid-phase synthesis of oxazoles 4 via Robinson-Gabriel reaction of solid-supported alpha-acylamino ketones 2 has been achieved. The reaction requires that the cyclization precursor be linked to a benzhydrylic-type linker (compounds 2) and that trifluoroacetic anhydride be used as the cyclodehydrating agent. The solvent has a dramatic effect on the latter reaction, which goes to completion and follows a cyclative-type mechanism only when an ethereal solvent is used. Different synthetic routes have been investigated toward assembling compounds 2. The most straightforward one, which we have validated more extensively, comprises the reaction of Merrifield alpha-methoxyphenyl (MAMP) resin with an alpha-amino ketone to form compounds 1, which are, in turn, acylated. Other methodologies and strategies allowing for the synthesis of compounds 1 that have been investigated include direct alkylation of Rink amide resin; reductive amination of the latter with alpha-keto aldehydes; reaction of MAMP resin with alpha-amino alcohols, followed by oxidation; and protection of Rink amide resin with either 2,4-dinitrosulfonyl or allyl group, followed by alkylation and removal of protecting group. In addition, we disclose a novel variant of the Ugi four-component reaction that allows for the preparation of compounds 2 in a single synthetic step.
- Published
- 2005
- Full Text
- View/download PDF
40. [Hemodynamic and oxygen transport effects of dobutamine in critically ill patients].
- Author
-
Pulici M, Crestan E, Decio B, D'Aloia A, Colombo AM, and Picozzi G
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Critical Illness, Dobutamine pharmacology, Hemodynamics drug effects, Oxygen metabolism
- Abstract
The study evaluates the cardiocirculatory and oxymetric effects of dobutamine infusion in doses between 5 and 15 g/kg/min for a period of 48 hours in 18 critical patients of whom 9 with a low cardiac index (mean 2.1) and 9 with a normal or increased cardiac index (mean 3.3). The beta mimetic effect of the drug is particularly evident in the 9 hypodynamic patients who benefited from a 28% increase in the cardiac index. Likewise, oxygen transport and consumption improved by 22% and 15% respectively. In overall terms, the variables which revealed significant modifications were: cardiac index (CI), systolic index (SI), mean pulmonary pressure (MPAP), pulmonary impaction pressure (PAWP), systemic and pulmonary vascular resistance (SVRO), PVRI), oxygen transport and consumption (DO2, VO2) (No major changes were observed in mean arterial pressure (MAP) and heart rate (HR). No tachyphylaxia was noted after 48 hours of continuous infusion.
- Published
- 1994
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.